What is SpaDerma?
SpaDerma operates as a leading medical spa, specializing in a comprehensive suite of advanced skincare treatments, cosmetic injectables, and laser therapy. With multiple established locations across Chicago, including Lincoln Park, West Loop, Lakeview, Wicker Park, and the North Shore, the company serves a broad clientele seeking effective solutions for dermatological concerns such as acne, aging, and hydration. SpaDerma is particularly recognized for its high volume of procedures, including popular treatments like Hydrafacial, SkinPen, and Moxi, positioning it as a key player in the competitive beauty and wellness industry.
How much funding has SpaDerma raised?
SpaDerma has raised a total of $780K across 2 funding rounds:
Debt
$350K
Debt
$430K
Debt (2020): $350K with participation from PPP
Debt (2021): $430K led by PPP
What's next for SpaDerma?
The recent major strategic investment signals SpaDerma's intent to accelerate its growth and potentially expand its market reach. This capital infusion is likely to be directed towards enhancing operational capabilities, potentially opening new locations, investing in cutting-edge technology, and broadening its service portfolio. As a company that has already demonstrated significant procedural volume and a strong brand presence in the Chicago market, this strategic backing positions SpaDerma for continued leadership and innovation within the rapidly evolving medical spa industry. The focus on strategic investment suggests a move towards consolidating its market share or exploring new avenues for service delivery and client engagement.
See full SpaDerma company page
